Find a job

Subscribe for free

All things Pharma

ABPI launches new prescribing support guide

The Association of the British Pharmaceutical Industry (ABPI) has launched a new guide to how the pharmaceutical industry can help healthcare professionals with complex...
- Advertisement -
- Advertisement -
- Advertisement -

Four tips for preparing your 2022 marketing strategy

I’ve spent the past two decades working in marketing roles within the global pharma...

Improving the patient treatment pathway

A clear, appropriate and best practice-based patient treatment pathway is crucial. Explore how to...

VPAG survey – have your say

Uniphar is asking industry to add its voice to a new survey on the 2024 VPAG with a view to understanding potential commercial and...

The NHS Major Conditions Strategy: What it means for Industry

Oli Hudson, Content Director at Wilmington Healthcare, explores the latest from the NHS on managing six major therapy areas. One of the NHS’s major policy...

Perspectives across the Breast Continuum of Care

Many healthcare professionals (HCPs) play an imperative role in the breast cancer pathway, and none work in isolation. It is essential that there is...

Subscribe for FREE

View all issues

- Advertisement -
- Advertisement -

NHS launches new BRCA gene testing programme

Tens of thousands of people with Jewish ancestry, who are more likely to carry a genetic fault that can increase the risk of developing...

Janssen seeks approval for its multiple myeloma treatment

Janssen has announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) seeking approval of talquetamab for the treatment of patients with relapsed or refractory multiple myeloma (RRMM). Talquetamab is an investigational, off-the-shelf (ready to...

Bristol Myers Squibb appoints new Senior Vice President and Head of Major Markets

Bristol Myers Squibb has announced that Dr Monica Shaw joins the company’s commercial leadership...

Pheon Therapeutics appoints new CEO

Pheon Therapeutics, an Antibody-Drug Conjugate (ADC) company developing next generation ADCs for a wide...

Destiny Pharma appoints new CEO

Destiny Pharma, a clinical stage innovative biotechnology company focused on the development of novel...


View all roles


On demand: Maximising pharma’s commercial impact with brand optimisation

Uniphar’s Client Solutions Director, Mark Ward, and Director of Consulting, Nick Bartlett, chair a Pf Media and Uniphar webinar, ‘Maximising pharma’s commercial impact with...


Sign up to receive our digital newsletter, for all the essential headlines, Jobs of the Week and thought-provoking features.

Claim my free subscription